Opioid-Free Anesthesia (OFA) as a Safe Anesthetic Choice for Epilepsy Patient
DOI:
https://doi.org/10.37275/bsm.v7i12.901Keywords:
Epilepsy, Nasal cavity tumor, Opioid-free anesthesia, RhinotomyAbstract
Background: The opioid-free anesthesia (OFA) approach, although not widely employed in anesthesia, offers distinct benefits for some populations, such as epilepsy patients, due to the propensity of opioids to trigger seizures. Hence, the objective of this study was to conduct an opioid-free anesthesia (OFA) procedure on the left lateral rhinotomy in a patient with concurrent epilepsy.
Case presentation: Our patient is a 59-year-old woman suffering from epilepsy with a left nasal cavity tumor, scheduled for a left midfacial degloving rhinotomy. Given the patient's epilepsy comorbid, we have opted for an opioid-free anesthesia (OFA) procedure. OFA procedures are not yet widely employed in anesthesia; however, they offer advantages for specific patient populations, including epilepsy patients, as opioids have the potential to induce seizures.
Conclusion: The various OFA protocols being conducted worldwide require refinement, and the potential interactions of each component should be explored further.
Authors
- Albertus Medianto Walujo1*
- Dewa Ayu Mas Shintya Dewi2
- FX. Adinda Putra Pradhana3
- 1Resident, Department of Anesthesiology and Intensive Therapy, Universitas Udayana/Prof. Dr. I.G.N.G Ngoerah General Hospital, Denpasar, Indonesia
- 2Department of Anesthesiology and Intensive Therapy, Universitas Udayana/Prof. Dr. I.G.N.G Ngoerah General Hospital, Denpasar, Indonesia
- 3Department of Anesthesiology and Intensive Therapy, Universitas Udayana, Udayana Hospital, Jimbaran, Indonesia
Corresponding author Albertus Medianto Walujo — medbius2022@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
